✦ LIBER ✦

Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receivinglow-dose oral methotrexate

✍ Scribed by P. Sonneveld; F. W. Schultz; K. Nooter; K. Hählen

Publisher: Springer
Year: 1986
Tongue: English
Weight: 523 KB
Volume: 18
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00262278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of methotrexate and 7-h

Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits

✍ Heiko Iven; Helmut Brasch; Jörg Engster 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 551 KB

In rabbits the IV kinetics of MTX (1.33, 4 and 12 mg/kg) could be described by a linear three-compartment model with a terminal half-life between 2.4 and 3.6 h. During 8 h 50% of the dose was excreted into urine in unchanged form and 15% as the metabolite 7-OH-MTX. These fractions remained constant

Renal excretion and pharmacokinetics of

Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children

✍ B. Winograd; R. J. J. Lippens; M. J. M. Oosterbaan; M. J. M. Dirks; T. B. Vree; 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 782 KB

Plasma and urine levels of methotrexate

Plasma and urine levels of methotrexate and 7-hydroxymethotrexate in children with all during maintenance therapy with weekly oral methotrexate

✍ Skoglund, Kathleen A. ;Söderhäll, Stefan ;Beck, Olof ;Peterson, Curt ;Wennberg, 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

## Abstract A new high‐performance liquid chromatographic assay was used to determine methotrexate (MTX) and its main metabolite, 7‐hydroxymethotrexate (7‐OH‐MTX), in the plasma (n ‐ 17) and urine (n = 14) of children (age 3‐12 years) on maintenance therapy for acute lymphocytic leukemia (n = 14) o

Pharmacokinetics of oral and intramuscul

Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia

✍ Andrew D. J. Pearson; Steven Mills; Helen A. Amineddine; David R. Long; Alan W. 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 515 KB

Pharmacokinetic modeling of plasma and c

Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in children

✍ E. Chatelut; H. Roche; Y. Plusquellec; F. Peyrille; J. De Biasi; A. Pujol; P. Ca 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

A pharmacokinetic study was performed in plasma and cerebrospinal fluid (CSF) of patients suffering from brain tumors to describe the disposition of methotrexate. An open three-compartment model was developed to fit together the data obtained in plasma and CSF. The pharmacokinetic parameters obtaine

Pharmacokinetic study of methotrexate, f

Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue

✍ C. Wolfrom; R. Hepp; R. Hartmann; H. Breithaupt; G. Henze 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 850 KB

The pharmacokinetics of methotrexate (MTX), 7-hydroxymethotrexate (7-OHMTX), 2,4-diaminomethylpteroic acid (APA), folinic acid, and 5-methyltetrahydrofolate (5-MTHF) have been studied during 21 high-dose MTX (HDMTX) infusions (5 g.m-2 in 24 h) with leucovorin (LCV) rescue, a component of the therapy